ReviewObesity pillars2024

Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks.

Wissam Ghusn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.